deoxycytidine has been researched along with Lymphopenia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belani, CP; Gusani, N; Jiang, Y; Kaifi, J; Kimchi, ET; Mackley, HB; Staveley-O'Carroll, KF; Zhu, J | 1 |
| Baba, J; Ichikawa, K; Igarashi, N; Ishikawa, D; Kagamu, H; Kondo, R; Koshio, J; Koya, T; Miura, S; Nakata, K; Narita, I; Nozaki, K; Okajima, M; Saida, Y; Sato, K; Shoji, S; Tanaka, J; Tanaka, T; Watanabe, S; Yoshizawa, H | 1 |
| Assadi, RK; Dholakia, AS; Ellsworth, SG; Ford, E; Grossman, SA; Hacker-Prietz, A; Herman, JM; Jaffee, EM; Laheru, DA; Lu, Y; Moningi, S; Pawlik, TM; Rosati, LM; Saeed, AM; Tran, PT; Weiss, MJ; Wild, AT; Wolfgang, CL; Ye, X | 1 |
| Foster, J; Lee, J; Urba, S; Worden, F; Zhang, J | 1 |
| Adjei, AA; Dy, GK; Eckhardt, SG; Jimeno, A; Ma, WW; Maniar, M; Messersmith, WA; Ren, C; Weekes, CD; Whitworth, A; Wilhelm, F | 1 |
| Kondo, Y; Nishisho, I; Sakamoto, J; Sakamoto, N; Takemiya, S | 1 |
| Staal, GE; Stoop, JW; Wadman, SK; Zegers, BJ | 1 |
| Smirnov, AD; Vladimirov, VG | 1 |
1 review(s) available for deoxycytidine and Lymphopenia
| Article | Year |
|---|---|
[Biological dosimetry in ionizing radiation exposure (a review of the literature)].
Topics: Animals; Bone Marrow; Chromosome Aberrations; Deoxycytidine; Deoxyuridine; DNA; Humans; Leukocytes; Lymphopenia; Mast Cells; Radiation Effects; Radiation Injuries; Radiometry; Time Factors | 1978 |
5 trial(s) available for deoxycytidine and Lymphopenia
| Article | Year |
|---|---|
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cohort Studies; Deoxycytidine; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphopenia; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Quinazolines; Radiography; Severity of Illness Index; Survival Analysis; Tumor Burden | 2014 |
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy; Deoxycytidine; Dose Fractionation, Radiation; Female; Fluorouracil; Gemcitabine; Humans; Lymphocyte Count; Lymphopenia; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Radiosurgery | 2016 |
A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Case-Control Studies; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome | 2010 |
Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cell Cycle Proteins; Cohort Studies; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Follow-Up Studies; Gemcitabine; Glycine; Humans; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Sulfones; Survival Analysis; Treatment Outcome | 2012 |
A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Drug Administration Schedule; Fluorouracil; Foot Dermatoses; Guideline Adherence; Hand Dermatoses; Humans; Hyperbilirubinemia; Japan; Lymphopenia; Middle Aged; Patient Selection; Survival Rate; Syndrome; Time Factors; Treatment Outcome | 2004 |
2 other study(ies) available for deoxycytidine and Lymphopenia
| Article | Year |
|---|---|
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Topics: Adoptive Transfer; Animals; Cisplatin; Cyclophosphamide; Cytotoxins; Deoxycytidine; Drug Resistance; Etoposide; Female; Fibrosarcoma; Gemcitabine; Lymph Nodes; Lymphocyte Depletion; Lymphopenia; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Vidarabine; Whole-Body Irradiation | 2015 |
An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient.
Topics: Antibody Formation; Deoxycytidine; Erythrocytes; Female; Humans; Immunologic Deficiency Syndromes; Infant; Leukocyte Count; Lymphocyte Activation; Lymphocytes; Lymphopenia; Nucleosides; Orotic Acid; Pentosyltransferases; Pokeweed Mitogens; Purine-Nucleoside Phosphorylase; T-Lymphocytes; Uric Acid | 1978 |